d-alpha tocopherol has been researched along with Cancer, Second Primary in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bairati, I; Brochet, F; Fortin, A; Gélinas, M; Meyer, F; Nabid, A; Nourissat, A; Têtu, B | 1 |
| Hong, WK; Kim, ES | 1 |
| Bairati, I; Brochet, F; del Vecchio, P; Fortin, A; Gélinas, M; Harel, F; Mâsse, B; Mercier, JP; Meyer, F; Nabid, A; Roy, J; Têtu, B; Vass, S; Vigneault, E | 1 |
| Bairati, I; Brochet, F; Fortin, A; Gélinas, M; Jobin, E; Lussier, S; Meyer, F; Nabid, A; Sackett, MK; Têtu, B | 1 |
| Khuri, FR; Kim, ES | 1 |
| Kuebler, AC; Scheer, M; Zöller, JE | 1 |
| Francisco, M; Hong, WK; Khuri, FR; Kim, E; Murphy, B; Richards, T; Seixas-Silva, JA; Shin, DM; Wieand, HS | 1 |
| Austin, DF; Blot, WJ; Day, GL; Greenberg, RS; Liff, JM; McLaughlin, JK; Preston-Martin, S; Sarkar, S; Schoenberg, JB; Shore, RE | 1 |
| Crespy, G | 1 |
| Bairati, I; Brochet, F; Gélinas, M; Mâsse, B; Meyer, F; Nabid, A; Roy, J; Têtu, B | 2 |
| Hong, WK | 1 |
| Hong, WK; Khuri, FR; Kim, ES | 1 |
| Ang, KK; Clayman, G; Francisco, M; Garden, AS; Gillenwater, A; Ginsberg, L; Glisson, BS; Goepfert, H; Hong, WK; Khuri, FR; Lippman, SM; Liu, D; Morrison, W; Murphy, B; Myers, J; Papadimitrakopoulou, V; Shin, DM | 1 |
| Clerici, M; Costa, A; De Palo, G; Formelli, F; Veronesi, U | 1 |
7 review(s) available for d-alpha tocopherol and Cancer, Second Primary
| Article | Year |
|---|---|
An apple a day...does it really keep the doctor away? The current state of cancer chemoprevention.
Topics: alpha-Tocopherol; Anticarcinogenic Agents; Antioxidants; beta Carotene; Biomarkers, Tumor; Double-Blind Method; Head and Neck Neoplasms; Humans; Multicenter Studies as Topic; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radiotherapy; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Failure; Treatment Outcome | 2005 |
Chemoprevention of lung cancer.
Topics: alpha-Tocopherol; Antioxidants; Carcinoma, Non-Small-Cell Lung; Double-Blind Method; Humans; Lung Neoplasms; Neoplasm Invasiveness; Neoplasms, Second Primary; Placebo Effect; Precancerous Conditions; Randomized Controlled Trials as Topic; Retinoids; Smoking Cessation | 2002 |
Chemoprevention of oral squamous cell carcinomas.
Topics: Antineoplastic Agents; Ascorbic Acid; Carcinoma, Squamous Cell; Carotenoids; Chemoprevention; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Neoplasms, Second Primary; Retinoids; Treatment Outcome; Vitamin E | 2004 |
[Prevention of second primary cancer with vitamin supplementation in patients treated for head and neck cancers].
Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; beta Carotene; Carcinoma, Squamous Cell; Carotenoids; Follow-Up Studies; Head and Neck Neoplasms; Humans; Neoplasm Staging; Neoplasms, Second Primary; Risk Factors; Vegetables; Vitamin A; Vitamin E; Vitamins | 1996 |
[Incidence and risk factors of second primary cancers in patients treated for primary pharyngeal cancer].
Topics: Canada; Head and Neck Neoplasms; Humans; Incidence; Lung Neoplasms; Neoplasms, Second Primary; Pharyngeal Neoplasms; Registries; Risk Factors; Vitamin A; Vitamin E | 1996 |
Chemoprevention of lung cancer.
Topics: Anticarcinogenic Agents; beta Carotene; Biomarkers; Carcinogens, Environmental; Chemoprevention; Clinical Trials as Topic; Genetic Markers; Genetic Predisposition to Disease; Humans; Lung Neoplasms; Neoplasms, Second Primary; Retinoids; Risk Factors; Smoking; Vitamin E | 1999 |
Prevention of lung cancer. The new millennium.
Topics: Carotenoids; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Genes, p53; Genes, ras; Humans; Lipoxygenase Inhibitors; Lung Neoplasms; Male; Mutation; Neoplasms, Second Primary; Phytotherapy; Precancerous Conditions; Primary Prevention; Proto-Oncogenes; Randomized Controlled Trials as Topic; Retinoids; Risk Factors; Selenium; Smoking; Smoking Cessation; Tea; Time Factors; Vitamin E | 2000 |
5 trial(s) available for d-alpha tocopherol and Cancer, Second Primary
| Article | Year |
|---|---|
Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer.
Topics: alpha-Tocopherol; beta Carotene; Body Weight; Carcinoma, Squamous Cell; Causality; Chemoprevention; Chemoradiotherapy; Comorbidity; Double-Blind Method; Eating; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mucositis; Neoplasm Staging; Neoplasms, Second Primary; Population Surveillance; Quality of Life; Radiotherapy; Risk Factors; Surveys and Questionnaires; Weight Loss | 2012 |
A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.
Topics: Adult; Aged; alpha-Tocopherol; Anticarcinogenic Agents; Antioxidants; beta Carotene; Confounding Factors, Epidemiologic; Double-Blind Method; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Incidence; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Odds Ratio; Proportional Hazards Models; Radiotherapy; Survival Analysis; Treatment Failure | 2005 |
Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer.
Topics: Aged; alpha-Tocopherol; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cyclooxygenase 2; Double-Blind Method; Female; Glottis; Head and Neck Neoplasms; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Laryngeal Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Placebos; Prognosis; Vitamins | 2008 |
Phase 2 bioadjuvant study of interferon alfa-2a, isotretinoin, and vitamin E in locally advanced squamous cell carcinoma of the head and neck: long-term follow-up.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Drug Therapy, Combination; Head and Neck Neoplasms; Humans; Interferon alpha-2; Interferon-alpha; Isotretinoin; Neoplasms, Second Primary; Prospective Studies; Recombinant Proteins; Vitamin E | 2005 |
Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Drug Synergism; Female; Head and Neck Neoplasms; Humans; Interferon-alpha; Isotretinoin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Survival Analysis; Survival Rate; Vitamin E | 2001 |
3 other study(ies) available for d-alpha tocopherol and Cancer, Second Primary
| Article | Year |
|---|---|
Dietary factors and second primary cancers: a follow-up of oral and pharyngeal cancer patients.
Topics: Aged; Case-Control Studies; Diet; Fabaceae; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasms, Second Primary; Pharyngeal Neoplasms; Plants, Medicinal; Risk Factors; Vegetables; Vitamin E; Vitamins | 1994 |
[Spontaneous recovery from metastatic cancer of the kidney. Favourable role of Vitamin E?].
Topics: Abdominal Neoplasms; Adenoma; Aged; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Male; Neoplasms, Second Primary; Nephrectomy; Prostatectomy; Prostatic Neoplasms; Remission, Spontaneous; Skin Neoplasms; Urinary Incontinence, Stress; Vitamin E | 1993 |
Chronic oral administration of fenretinide, as a chemopreventive agent to breast cancer patients, does not affect plasma alpha-tocopherol concentration.
Topics: Administration, Oral; Adult; Breast Neoplasms; Female; Fenretinide; Humans; Middle Aged; Neoplasms, Second Primary; Tretinoin; Vitamin E | 1991 |